[{"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2657G>A (*9B)": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2978T>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3049G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3061G>C/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3067C>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.313G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.343A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.451A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.46C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.62G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.85T>C (*9A)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"Reference/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 2}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2978T>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2978T>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2978T>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3049G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3049G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3061G>C/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.343A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.343A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.451A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.451A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.496A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.498G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.313G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.313G>A": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.451A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.451A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.496A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.498G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.343A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.343A>G": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.496A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.498G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.451A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.451A>G": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.313G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.313G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.343A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.343A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.451A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.451A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.496A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.498G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.62G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.62G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.85T>C (*9A)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.46C>G": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.498G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.496A>G": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.498G>A": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.525G>A": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.313G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.313G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.343A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.343A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.451A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.451A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.496A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.496A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.498G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.498G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.525G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.525G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.775A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.85T>C (*9A)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.62G>A": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.775A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.929T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.775A>G": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.929T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.934C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.929T>C": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.934C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.967G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.934C>T": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1003G>T (*11)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1108A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1180C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1181G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1218G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1260T>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1278G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1294G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1349C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1358C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1371C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1403C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1519G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1543G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1577C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1601G>A (*4)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1615G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1627A>G (*5)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1682G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1796T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1896T>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1905C>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1906A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1990G>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2161G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2186C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2194G>A (*6)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2195T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2303C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2336C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2482G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2582A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2623A>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2656C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2915A>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2921A>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2977C>T","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2978T>G","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.3049G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.3061G>C","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.3067C>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.967G>A","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"c.967G>A": 1, "Reference": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1003G>T (*11)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1108A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1180C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1181G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1218G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1260T>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1278G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1294G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1349C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1358C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1371C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1403C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1519G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1543G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1577C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1601G>A (*4)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1615G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1627A>G (*5)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1682G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1796T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1896T>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1905C>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1906A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.1990G>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2161G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2186C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2194G>A (*6)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2195T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2303C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2336C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2482G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2582A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2623A>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2656C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2657G>A (*9B)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2915A>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2921A>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2977C>T": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2978T>G/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.2978T>G": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3049G>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.3049G>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3061G>C/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.3061G>C": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.3067C>A/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.3067C>A": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/Reference","function1":"Normal function","function2":"Normal function","activityvalue1":"1.0","activityvalue2":"1.0","totalactivityscore":"2.0","description":"An individual carrying two normal function alleles","diplotypekey":{"DPYD": {"Reference": 1, "c.85T>C (*9A)": 1}},"generesult":"Normal Metabolizer","ehrpriority":"Normal/Routine/Low Risk","consultationtext":"This result signifies that the patient has two copies of normal function DPYD alleles. Based on the genotype result this patient is predicted to be DPYD Normal Metabolizer with a DPYD activity score of 2. For this genotype, no selective dose adjustment is indicated for medications that are metabolized by DPD. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "2.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1601G>A (*4)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1627A>G (*5)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2194G>A (*6)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1180C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1180C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1181G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1181G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1218G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1218G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1260T>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1260T>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1278G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1278G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1294G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1294G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1349C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1358C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1371C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1403C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1519G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1543G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1577C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1601G>A (*4)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1615G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1627A>G (*5)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1682G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1796T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1896T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1905C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1906A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1990G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2161G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2186C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2194G>A (*6)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2195T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2303C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2336C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2482G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2582A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2623A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2656C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1349C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1349C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1358C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1358C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1371C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1371C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1403C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1403C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1519G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1519G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1543G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1543G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1577C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1577C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1601G>A (*4)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1615G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1615G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1627A>G (*5)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1682G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1682G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1796T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1796T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1896T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1896T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1905C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1905C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1906A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1906A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1990G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1990G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2161G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2161G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2186C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2186C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2194G>A (*6)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2195T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2195T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2303C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2336C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2482G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2582A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2623A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2656C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2303C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2303C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2336C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2336C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2482G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2482G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2582A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2582A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2623A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2623A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2656C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2656C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2657G>A (*9B)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2657G>A (*9B)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1003G>T (*11)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1108A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1180C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1181G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1218G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1260T>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1278G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1294G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1349C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1358C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1371C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1403C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1519G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1543G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1577C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1615G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1682G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1796T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1896T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1905C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1906A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1990G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2161G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2186C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2195T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2303C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2336C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2482G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2582A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2623A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2656C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.775A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.775A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.929T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.929T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.934C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.934C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.967G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.967G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "Reference": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.557A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.557A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1003G>T (*11)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1108A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1180C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1181G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1218G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1260T>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1278G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1294G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1349C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1358C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1371C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1403C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1519G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1543G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1577C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1601G>A (*4)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1615G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1627A>G (*5)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1682G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1796T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1896T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1905C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1906A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1990G>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2161G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2186C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2194G>A (*6)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2195T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2303C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2336C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2482G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2582A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2623A>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2656C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2915A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2921A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2977C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2978T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.3049G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.3061G>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.3067C>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.868A>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.929T>C","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.929T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.934C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.934C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.967G>A","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.967G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "Reference": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1129-5923C>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1314T>G","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2279C>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2846A>T","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/Reference","function1":"Normal function","function2":"Decreased function","activityvalue1":"1.0","activityvalue2":"0.5","totalactivityscore":"1.5","description":"An individual carrying one normal function allele and one decreased function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a normal function allele and one copy of a decreased function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1003G>T (*11)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1003G>T (*11)": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1108A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1108A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1180C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1180C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1181G>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1181G>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1218G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1218G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1260T>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1260T>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1278G>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1278G>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1294G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1294G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1349C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1349C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1358C>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1358C>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1371C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1371C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1403C>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1403C>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1519G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1519G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1543G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1543G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1577C>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1577C>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1601G>A (*4)": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1615G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1615G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1627A>G (*5)": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1682G>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1682G>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1796T>C/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1796T>C": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1896T>C/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1896T>C": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1898delC (*3)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905C>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905C>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1906A>C/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1906A>C": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1990G>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.1990G>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2161G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2161G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2186C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2186C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2194G>A (*6)": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2195T>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2195T>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2303C>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2303C>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2336C>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2336C>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2482G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2482G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2582A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2582A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2623A>C/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2623A>C": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2656C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2656C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2657G>A (*9B)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2657G>A (*9B)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2657G>A (*9B)": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2915A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2915A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2921A>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2921A>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1003G>T (*11)/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1601G>A (*4)/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1627A>G (*5)/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2194G>A (*6)/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2657G>A (*9B)/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2977C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2977C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2978T>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.2978T>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2983G>T (*10)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3049G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2983G>T (*10)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3061G>C": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2983G>T (*10)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.3067C>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.313G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.313G>A/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.313G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.343A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.343A>G/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.343A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.451A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.451A>G/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.451A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.295_298delTCAT (*7)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.61C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.61C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.46C>G/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.46C>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.496A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.496A>G/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.496A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.498G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.498G>A/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.498G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.525G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.525G>A/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.525G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1003G>T (*11)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.775A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.775A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.929T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.929T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.934C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.934C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.967G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.967G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "Reference": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1003G>T (*11)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.313G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.313G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.343A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.343A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.451A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.451A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.496A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.496A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.498G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.498G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.525G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.525G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.62G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.62G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.775A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.775A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.85T>C (*9A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.929T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.929T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.934C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.934C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.967G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.967G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "Reference": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.295_298delTCAT (*7)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.601A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.601A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.632A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.62G>A/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.62G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1003G>T (*11)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1108A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1108A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1180C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1180C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1181G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1181G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1218G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1218G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1260T>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1260T>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1278G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1278G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1294G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1294G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1349C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1349C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1358C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1358C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1371C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1371C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1403C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1403C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1519G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1519G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1543G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1543G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1577C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1577C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1615G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1615G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1682G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1682G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1796T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1796T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1896T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1896T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1905C>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1905C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1906A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1906A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1990G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1990G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2161G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2161G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2186C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2186C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2195T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2195T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2303C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2303C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2336C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2336C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2482G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2482G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2582A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2582A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2623A>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2623A>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2656C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2656C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2915A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2915A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2921A>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2921A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2977C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2977C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2978T>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2978T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.3049G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.3049G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.3061G>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.3061G>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.3067C>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.3067C>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.775A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.775A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.632A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.929T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.929T>C": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.934C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.934C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.967G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.967G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "Reference": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1003G>T (*11)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1003G>T (*11)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1601G>A (*4)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1601G>A (*4)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1627A>G (*5)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1627A>G (*5)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2194G>A (*6)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.2194G>A (*6)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2657G>A (*9B)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.2657G>A (*9B)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.703C>T (*8)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.85T>C (*9A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.775A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.775A>G/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.775A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.775A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.295_298delTCAT (*7)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.85T>C (*9A)/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.85T>C (*9A)": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.929T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.929T>C/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.929T>C","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.929T>C": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.934C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.934C>T/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.934C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.934C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1024G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1057C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1156G>T (*12)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1475C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1484A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1679T>G (*13)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1774C>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1775G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1777G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1898delC (*3)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.1905+1G>A (*2A)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2021G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2639G>T","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2872A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2933A>G","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.967G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.967G>A/c.2983G>T (*10)","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.967G>A","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"c.967G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1024G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1057C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1156G>T (*12)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1475C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1484A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1679T>G (*13)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1774C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1775G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1777G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1898delC (*3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2021G>A": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2639G>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2872A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2933A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2983G>T (*10)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.2983G>T (*10)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/Reference","function1":"Normal function","function2":"No function","activityvalue1":"1.0","activityvalue2":"0.0","totalactivityscore":"1.0","description":"An individual carrying one normal function allele and one no function allele","diplotypekey":{"DPYD": {"Reference": 1, "c.703C>T (*8)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1129-5923C>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1129-5923C>G": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1129-5923C>G, c.1236G>A (HapB3)": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1314T>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1314T>G": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2279C>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2279C>T": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2846A>T": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.557A>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.868A>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.868A>G": 2}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1314T>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1314T>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2279C>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2279C>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2279C>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1129-5923C>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1314T>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2279C>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.868A>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.868A>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1129-5923C>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1314T>G","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1314T>G": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2279C>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2279C>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2846A>T","function1":"Decreased function","function2":"Decreased function","activityvalue1":"0.5","activityvalue2":"0.5","totalactivityscore":"1.0","description":"An individual carrying two decreased function alleles","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2846A>T": 1}},"generesult":"Intermediate Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has either one copy of a normal function allele and one copy of a no function allele of the DPYD gene OR two copies of decreased function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Intermediate Metabolizer with a DPYD activity score of 1. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "1.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1314T>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1314T>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1156G>T (*12)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1679T>G (*13)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1898delC (*3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1905+1G>A (*2A)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1129-5923C>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1156G>T (*12)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1475C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1484A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1679T>G (*13)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1774C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1775G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1777G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1898delC (*3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.1905+1G>A (*2A)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2021G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2639G>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1314T>G/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1314T>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1475C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1475C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1484A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1484A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1679T>G (*13)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1774C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1774C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1775G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1775G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.1777G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1777G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1898delC (*3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1898delC (*3)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.1905+1G>A (*2A)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.1905+1G>A (*2A)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2021G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2021G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2639G>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2279C>T/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2279C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2639G>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2639G>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2846A>T/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2846A>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.295_298delTCAT (*7)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1129-5923C>G, c.1236G>A (HapB3)/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.2983G>T (*10)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1024G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1024G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1057C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1057C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1156G>T (*12)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1475C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1484A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1679T>G (*13)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1774C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1775G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1777G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1898delC (*3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.1905+1G>A (*2A)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2021G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2639G>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.557A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.601A>C","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.601A>C": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.632A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.632A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.557A>G/c.703C>T (*8)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.557A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1314T>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.868A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.868A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1314T>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.557A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.557A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.868A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.868A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1314T>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1314T>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2279C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2279C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2846A>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2846A>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.868A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.868A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1129-5923C>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1129-5923C>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1129-5923C>G, c.1236G>A (HapB3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1129-5923C>G, c.1236G>A (HapB3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1024G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1024G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1057C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1057C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1156G>T (*12)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1475C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1484A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1679T>G (*13)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1774C>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1775G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1777G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1898delC (*3)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.1905+1G>A (*2A)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2021G>A","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2639G>T","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2872A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2933A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.868A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.868A>G/c.2983G>T (*10)","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.868A>G","function1":"Decreased function","function2":"No function","activityvalue1":"0.5","activityvalue2":"0.0","totalactivityscore":"0.5","description":"An individual carrying one decreased function allele and one no function allele","diplotypekey":{"DPYD": {"c.868A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has one copy of a decreased function allele and one copy of a no function allele of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0.5. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and a dose adjustment or alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.5"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1024G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1898delC (*3)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1905+1G>A (*2A)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.295_298delTCAT (*7)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.295_298delTCAT (*7)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2983G>T (*10)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2983G>T (*10)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.601A>C","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.61C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.632A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.703C>T (*8)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 2}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1057C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1024G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1024G>A/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1024G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1024G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1057C>T/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1057C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1156G>T (*12)": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1475C>T/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1475C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1484A>G/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1484A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1679T>G (*13)": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1774C>T/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1774C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1775G>A/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1775G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1777G>A/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1777G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1898delC (*3)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1898delC (*3)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1898delC (*3)": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.1905+1G>A (*2A)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2021G>A/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2021G>A": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2639G>T/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2639G>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2872A>G/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2872A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1156G>T (*12)/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1679T>G (*13)/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1898delC (*3)/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.2933A>G/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2933A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.1905+1G>A (*2A)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2983G>T (*10)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.2983G>T (*10)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1024G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1024G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1057C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.601A>C","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.632A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.632A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.601A>C/c.703C>T (*8)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.601A>C": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1024G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1024G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1057C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.295_298delTCAT (*7)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.601A>C","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.601A>C": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.632A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.632A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.61C>T/c.703C>T (*8)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.61C>T": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1024G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1024G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1057C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1057C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1475C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1475C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1484A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1484A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1774C>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1774C>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1775G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1775G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1777G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1777G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2021G>A","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2021G>A": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2639G>T","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2639G>T": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2872A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2872A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2933A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2933A>G": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.632A>G","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.632A>G/c.703C>T (*8)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.632A>G": 1, "c.703C>T (*8)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1156G>T (*12)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1156G>T (*12)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1679T>G (*13)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1679T>G (*13)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1898delC (*3)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1898delC (*3)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.1905+1G>A (*2A)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.1905+1G>A (*2A)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.295_298delTCAT (*7)/c.703C>T (*8)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.295_298delTCAT (*7)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}, 
 {"genesymbol":"DPYD","diplotype":"c.703C>T (*8)/c.2983G>T (*10)","function1":"No function","function2":"No function","activityvalue1":"0.0","activityvalue2":"0.0","totalactivityscore":"0.0","description":"An individual carrying two no function alleles","diplotypekey":{"DPYD": {"c.703C>T (*8)": 1, "c.2983G>T (*10)": 1}},"generesult":"Poor Metabolizer","ehrpriority":"Abnormal/Priority/High Risk","consultationtext":"This result signifies that the patient has two copies of no function alleles of the DPYD gene. Based on the genotype result this patient is predicted to be a DPYD Poor Metabolizer with a DPYD activity score of 0. This patient may be at risk for adverse drug reactions to medications that are metabolized by DPD (i.e. 5-fluorouracil, capecitabine, and tegafur) and alternative therapeutic agents may be indicated. Please consult a clinical pharmacist for more information about how DPD metabolic status influences drug selection and dosing.","lookupkey":{"DPYD" : "0.0"}}]